Ventas (VTR) Declares $0.79 Quarterly Dividend; 6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
A bid to save $300 million at HCR ManorCare, and disrupt U.S. healthcare
May 15, 2018 7:04 AM EDTBy Tracy Rucinski
CHICAGO (Reuters) - Thomas DeRosa is making a $4 billion bet that he can build a national, low-cost healthcare network for America's aging population that will succeed where so many other models have struggled.
His secret: strip out the "for-profit" business model, and leverage the real estate in nursing homes for outpatient care.
DeRosa's strategy starts with buying out the property of the huge bankrupt nursing home chain HCR ManorCare, and teaming up with a non-profit hospital operator, ProMedica, to create a 30-state healthcare system.
His own company, real estate investment trust Welltower... More
Ventas (VTR) PT Lowered to $62 at RBC Capital
May 14, 2018 7:33 AM EDTRBC Capital lowered its price target on Ventas (NYSE: VTR) to $62.00 (from $63.00) while maintaining a Outperform rating.
... More